Document Detail


ATM deficiency augments constitutively nuclear cyclin D1-driven genomic instability and lymphomagenesis.
MedLine Citation:
PMID:  23318439     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cyclin D1 deregulation is implicated in the genesis of multiple human cancers. Importantly, nuclear cyclin D1 retention during S-phase promotes DNA re-replication and subsequent genomic instability, providing a direct correlation between aberrant cyclin D1/CDK4 activity, transcriptional regulation and double strand DNA break (DSB) induction. Together, these molecular events catalyze the genomic instability necessary for neoplastic transformation. Given that replication-associated DNA damage is central to cyclin D1-driven neoplasia, inactivation of critical checkpoint mediators should augment cyclin D1-dependent tumorigenesis in vivo. To interrogate potential synergy between constitutively nuclear cyclin D1 expression and impaired DSB-induced checkpoint integrity, Ataxia Telangiectasia Mutated (ATM)-deficient mice harboring the Eμ-D1T286A transgene were generated and evaluated for tumor onset. Eμ-D1T286A/ATM-/- mice exhibit dramatically accelerated incidence of both B- and T-cell lymphomas relative to Eμ-D1T286A or ATM-/- control cohorts. Lymphomas exhibit clonal chromosomal alterations distinct from ATM-/- mice, which typically acquire translocations involving the Tcrα/δ locus during V(D)J recombination, and instead harbor alterations at the c-Myc locus. Collectively, these findings reveal an intricate relationship wherein nuclear cyclin D1/CDK4 drives genomic instability in the absence of ATM function and clonal selection of cells harboring alterations within the murine c-Myc locus, ultimately facilitating transformation and tumor formation.
Authors:
L P Vaites; Z Lian; E K Lee; B Yin; A DeMicco; C H Bassing; J A Diehl
Related Documents :
24815909 - Potential roles for interactions between the mitochondrial and nuclear dna throughout t...
12010969 - Vaccination with plasmid dna encoding tsa/lmsti1 leishmanial fusion proteins confers pr...
24957619 - Dna ligase c1 mediates the ligd independent nhej pathway of mycobacterium smegmatis.
24115439 - Rtel1 is a replisome-associated helicase that promotes telomere and genome-wide replica...
23708749 - A reusable quartz crystal microbalance biosensor for highly specific detection of singl...
14610909 - Dna vaccination.
1356139 - Differentiation of mosquito-pathogenic strains of bacillus sphaericus from non-toxic va...
10512709 - Large-scale effects of transcriptional dna supercoiling in vivo.
15341749 - Scc2 couples replication licensing to sister chromatid cohesion in xenopus egg extracts.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2013-01-14
Journal Detail:
Title:  Oncogene     Volume:  33     ISSN:  1476-5594     ISO Abbreviation:  Oncogene     Publication Date:  2014 Jan 
Date Detail:
Created Date:  2014-01-03     Completed Date:  2014-03-03     Revised Date:  2014-08-05    
Medline Journal Info:
Nlm Unique ID:  8711562     Medline TA:  Oncogene     Country:  England    
Other Details:
Languages:  eng     Pagination:  129-33     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Ataxia Telangiectasia Mutated Proteins / deficiency,  genetics
Carcinogenesis / genetics*,  metabolism
Cell Nucleus / metabolism
Chromosome Aberrations
Cyclin D1 / metabolism*
Genomic Instability*
Humans
Lymphoma / genetics*,  metabolism
Mice
Mice, Knockout
Protein Transport
Proto-Oncogene Proteins c-myc / metabolism
Tumor Burden
Grant Support
ID/Acronym/Agency:
CA93237/CA/NCI NIH HHS; R01 CA093237/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Ccnd1 protein, mouse; 0/Myc protein, mouse; 0/Proto-Oncogene Proteins c-myc; 136601-57-5/Cyclin D1; EC 2.7.11.1/Ataxia Telangiectasia Mutated Proteins; EC 2.7.11.1/Atm protein, mouse
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  WASF3 regulates miR-200 inactivation by ZEB1 through suppression of KISS1 leading to increased invas...
Next Document:  The PI3K inhibitor GDC-0941 combines with existing clinical regimens for superior activity in multip...